Backed by our rich industry experience in this domain, we are offering a wide array of
Erlotinib Tablets IP to our valuable clients. The offered products are works by interfering with the protein epidermal growth factor to remove it from cancer cells which require to multiply, grow and spread. These products are used for the treatment of metastatic Non-Small Cell Lung cancer.
Features:
- Balanced formulation
- Free from impurities
- Long shelf life
Other Details:
- It contains Drug / Molecules called “Erlotinib”
- It belongs to Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors
- The medication works by interfering with the protein epidermal growth factor to prevent it from activating enzymes, cancer cells require these to multiply, grow and spread
- 150
Indication:
- Erlotinib is used for the treatment of advance or metastatic Non-Small Cell Lung cancer
Additional Information: